A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO ASSESS THE EFFICACY AND SAFETY OF SOLRIAMFETOL IN EXCESSIVE SLEEPINESS ASSOCIATED WITH SHIFT WORK DISORDER.

Registry ID

SOL-SWD-301

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

AXSOME THERAPEUTICS, INC.

Start date

2025-09-19

Last update

2025-08-05

Conditions

• SLEEP DISORDER

View on source registry